These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 19475539)

  • 41. Sertindole in schizophrenia: efficacy and safety issues.
    Muscatello MR; Bruno A; Micali Bellinghieri P; Pandolfo G; Zoccali RA
    Expert Opin Pharmacother; 2014 Sep; 15(13):1943-53. PubMed ID: 25084209
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Modeling of brain D2 receptor occupancy-plasma concentration relationships with a novel antipsychotic, YKP1358, using serial PET scans in healthy volunteers.
    Lim KS; Kwon JS; Jang IJ; Jeong JM; Lee JS; Kim HW; Kang WJ; Kim JR; Cho JY; Kim E; Yoo SY; Shin SG; Yu KS
    Clin Pharmacol Ther; 2007 Feb; 81(2):252-8. PubMed ID: 17259948
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dopamine D(2) receptor occupancy is a common mechanism underlying animal models of antipsychotics and their clinical effects.
    Wadenberg ML; Soliman A; VanderSpek SC; Kapur S
    Neuropsychopharmacology; 2001 Nov; 25(5):633-41. PubMed ID: 11682246
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Sertindole, a novel alpha 1A-adrenoceptor selective antagonist].
    Zhang YY; Lu ZZ; Wei H; Han QD
    Yao Xue Xue Bao; 1997 Jul; 32(7):490-5. PubMed ID: 11596272
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Role of D2 dopamine receptors of the ventral pallidum in inhibitory avoidance learning.
    Lénárd L; Ollmann T; László K; Kovács A; Gálosi R; Kállai V; Attila T; Kertes E; Zagoracz O; Karádi Z; Péczely L
    Behav Brain Res; 2017 Mar; 321():99-105. PubMed ID: 28057528
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lack of multiple dosing effect of sertindole on the pharmacokinetics of alprazolam in healthy volunteers.
    Wong SL; Locke C; Staser J; Granneman GR
    Psychopharmacology (Berl); 1998 Feb; 135(3):236-41. PubMed ID: 9498726
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Targeting G Protein-Coupled Receptors by Capture Compound Mass Spectrometry: A Case Study with Sertindole.
    Blex C; Michaelis S; Schrey AK; Furkert J; Eichhorst J; Bartho K; Gyapon Quast F; Marais A; Hakelberg M; Gruber U; Niquet S; Popp O; Kroll F; Sefkow M; Schülein R; Dreger M; Köster H
    Chembiochem; 2017 Aug; 18(16):1639-1649. PubMed ID: 28557180
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [The role of immobilization stress and sertindole on the expression of APP, MAPK-1 and beta-actin genes in rat brain].
    Kállmán J; Pákáski M; Szucs S; Kálmán S; Fazekas O; Santha P; Szabó G; Janka Z; Kálmán J
    Ideggyogy Sz; 2012 Nov; 65(11-12):394-400. PubMed ID: 23289174
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The role of nucleus accumbens and dorsolateral striatal D2 receptors in active avoidance conditioning.
    Boschen SL; Wietzikoski EC; Winn P; Da Cunha C
    Neurobiol Learn Mem; 2011 Sep; 96(2):254-62. PubMed ID: 21619938
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Repeated administration of aripiprazole produces a sensitization effect in the suppression of avoidance responding and phencyclidine-induced hyperlocomotion and increases D2 receptor-mediated behavioral function.
    Gao J; Qin R; Li M
    J Psychopharmacol; 2015 Apr; 29(4):390-400. PubMed ID: 25586399
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pharmacodynamics of cibenzoline-induced hypoglycemia in rats.
    Takahashi Y; Ishiwata Y; Kojima Y; Yasuhara M
    Drug Metab Pharmacokinet; 2011 Jun; 26(3):242-7. PubMed ID: 21273730
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pharmacokinetic and pharmacodynamic analyses, based on dopamine D2-receptor occupancy of bromocriptine, of bromocriptine-induced contralateral rotations in unilaterally 6-OHDA-lesioned rats.
    Atsumi M; Kawakami J; Sugiyama E; Kotaki H; Sawada Y; Sato H; Yamada Y; Iga T
    Synapse; 2003 Nov; 50(2):110-6. PubMed ID: 12923813
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pharmacological profiles in rats of novel antipsychotics with combined dopamine D2/serotonin 5-HT1A activity: comparison with typical and atypical conventional antipsychotics.
    Bardin L; Auclair A; Kleven MS; Prinssen EP; Koek W; Newman-Tancredi A; Depoortère R
    Behav Pharmacol; 2007 Mar; 18(2):103-18. PubMed ID: 17351418
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Disposition of pentopril, a new orally active angiotensin-converting enzyme inhibitor, and its active metabolite in rats.
    Rakhit A; Kochak G; Dotson R; Tipnis V
    J Pharm Sci; 1985 Sep; 74(9):947-52. PubMed ID: 2999376
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Use of LC/MS to assess brain tracer distribution in preclinical, in vivo receptor occupancy studies: dopamine D2, serotonin 2A and NK-1 receptors as examples.
    Chernet E; Martin LJ; Li D; Need AB; Barth VN; Rash KS; Phebus LA
    Life Sci; 2005 Dec; 78(4):340-6. PubMed ID: 16139310
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmacokinetic-pharmacodynamic modelling in the early development phase of anti-psychotics: a comparison of the effects of clozapine, S 16924 and S 18327 in the EEG model in rats.
    Parker TJ; Della Pasqua OE; Loizillon E; Chezaubernard C; Jochemsen R; Danhof M
    Br J Pharmacol; 2001 Jan; 132(1):151-8. PubMed ID: 11156572
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Contrasting loxapine to its isomer isoloxapine--the critical role of in vivo D2 blockade in determining atypicality.
    Natesan S; Vanderspek S; Nobrega JN; McClelland RA; Kapur S
    Schizophr Res; 2005 Sep; 77(2-3):189-99. PubMed ID: 15925489
    [TBL] [Abstract][Full Text] [Related]  

  • 58. D2 receptor occupancy in conscious rat brain is not significantly distinguished with [3H]-MNPA, [3H]-(+)-PHNO, and [3H]-raclopride.
    Peng T; Zysk J; Dorff P; Elmore CS; Ström P; Malmquist J; Ding M; Tuke D; Werkheiser J; Widzowski D; Mrzljak L; Maier D
    Synapse; 2010 Aug; 64(8):624-33. PubMed ID: 20340171
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pharmacokinetic/Pharmacodynamic Modelling of Receptor Internalization with CRTH2 Antagonists to Optimize Dose Selection.
    Krause A; Zisowsky J; Strasser DS; Gehin M; Sidharta PN; Groenen PMA; Dingemanse J
    Clin Pharmacokinet; 2016 Jul; 55(7):813-821. PubMed ID: 26692193
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pharmacological profile of the atypical neuroleptic sertindole.
    Hyttel J; Arnt J; Costall B; Domeney A; Dragsted N; Lembøl HL; Meier E; Naylor RJ; Nowak G; Sánchez C
    Clin Neuropharmacol; 1992; 15 Suppl 1 Pt A():267A-268A. PubMed ID: 1354033
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.